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Abstract
The epidemiology of malaria has always varied between different parts of the world because of
widely varying vectorial capacity.  Mortality from malaria can be measured from clinical records
or the rise of mortality during an epidemic, but better from observing the fall of mortality during
control or from the population frequency of protective host genes.  Holoendemic malaria may
have doubled the infant and young-child mortality rate in Africa in the recent past, but death
rates have fallen because of chemotherapy.  The epidemiological pattern is changing.  In the
Sahel, water-resource developments tend to lengthen the transmission season, though less than
might be expected, and urbanization tends to decrease transmission in Africa, not in Asia.  The
spread of multiple drug resistance of the parasites is making case management harder and deaths
may rise.  Malaria control has always been unsatisfactory in sub-Saharan Africa owing to the
highly effective vector.  The main current hopes for control are the use of the effective insecticide-
impregnated bed nets and better case management.  No simple concept of an epidemiological
transition can reflect the very diverse changes occurring in human malaria worldwide.
Introduction
Malaria is, and has been, the most important parasitic disease of man in terms of mortality, morbidity
and effects upon life generally, using ‘parasitic’ in its narrower meaning of the animal parasites: worms
and protozoa.  The malaria parasites are of great antiquity: they evolved along with man so that there
are four malaria parasites specific to man, and other related parasites specific to the various great apes,
monkeys, and other mammals.  In spite of this long-term host-parasite relationship, there have been
major epidemiological changes in human malaria over the last fifty years and they are taking place at an
accelerating rate.  This paper sets out the basic principles of quantitative malaria epidemiology, without
which any attempts to understand changes would be meaningless; and describes the main
epidemiological changes that are taking place.
An important genetic polymorphism in man, the sickle-cell gene, appears to be maintained by the
protection it affords against human malaria and this is used to estimate the mortality due to human
malaria, particularly in Africa, in the past.  This is compared with the limited historical data on recorded
mortality, and the possible causes of falling mortality are discussed.  The results are related, though
uncomfortably, to the concept of the health transition.  The complex interaction of biology of the vector,
present health-care, history of the use of medicines and insecticides, migration and environmental
change does not fit simply into the idea of a single unidirectional process.  There is considerable
epidemiological material before these last issues are reached.  The presentation focuses on the historical
and health-transition issues.
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Malaria: background to epidemiology
There are four malaria parasites of man.  Three of them, Plasmodium vivax, P. malariae and P. ovale,
are the cause of intermittent high fevers in man that can make a person very ill but are rarely fatal.  The
remaining species, P. falciparum, is the cause of malignant tertian, or falciparum, malaria which has a
substantial mortality if it is untreated, especially in the first or an early attack.  Following a single
infection, there is intermittent presence of the parasites in the blood for several months.  In people
subject to frequent infective mosquito bites, the parasitaemia will continue throughout childhood.
Figure 1
The cycle of malaria transmission and course of disease, with determinants
The basic transmission cycle of the malaria parasites is seen in the central part of Figure 1.  The
sexual stages of the parasite develop in the blood of someone who has been infected for some time.
Mosquitoes of the genus Anopheles become infected by feeding on that person.  The parasites develop
in the mosquito at a rate dependent on the ambient temperature but in the tropics usually take about
twelve days before the maturing parasites have reached the mosquito’s salivary glands ready to infect
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the next person on whom the mosquito feeds.  It will remain infective for the rest of its life.  The
interval between the mosquito becoming infected and being first able to pass on the infection is known
as the duration of the extrinsic cycle.  When someone is bitten by the infective mosquito the parasites
pass to the liver, develop in the cells there, and then burst out to infect the red cells of the blood.  The
parasites multiply, usually synchronously, in the red cells and go through this cycle every 48 hours
except for P. malariae in which the duration is 72 hours.  With each red-cell cycle the parasites increase
logarithmically and as the cells burst the classical attacks of fever occur, hence the intermittent fever
pattern known as far back as Hippocrates.  As the proportion of infected red cells increases, so do the
fevers.  In falciparum malaria the infected red cells become sticky and adhere to the lining of the
capillaries of the brain.  They use up the blood’s oxygen and prevent it reaching the brain so that the
patient may go into a coma and die: cerebral malaria.
People who become infected, and are not immune, suffer a classical unmodified attack of clinical
malaria with a severe intermittent fever.  Their attacks get worse, usually occurring every other day in
Plasmodium vivax infections, and on alternate days but more irregularly in cases of P. falciparum,
which gives rise to more severe disease and a mortality of five to ten per cent in those remaining
untreated.  Malaria morbidity in very highly endemic areas is mainly a feature of infancy and may
account for 30–35 per cent of the cases seeking health care at rural dispensaries.  It is evenly spread
through the year in the forest form and may vary between ten per cent and 80 per cent of childhood
fevers in the savannah zone.  Some data suggests that mortality may reach its peak in the savannah,
where malaria may be combined with malnutrition, maternal overwork, and lack of drugs in the season
of maximal transmission.
The basic quantitative epidemiology of malaria
Malaria varies dramatically in its epidemiological pattern.  In some places it appears as massive
epidemics affecting people of all ages and causing temporary social disruption comparable to a very
severe influenza epidemic.  This pattern, alternating between large epidemics and scarce malaria, is
called unstable malaria.  At the other extreme is very stable malaria, where transmission is continuous,
or regularly seasonal, and everyone is being infected and reinfected by mosquitoes.  Unstable and stable
malaria not only differ in their mortality and public-health effects, they are also very different in their
responses to attempts at control.  In particular, similarly energetic control measures may have
completely different outcomes in different areas.  These differences are biologically determined and
must be understood if naive generalizations are to be avoided: for example, there was a tendency to
blame the failure of malaria eradication in Africa on defective health services, whereas the problem was
biologically intractable even with good health services.
The reasons for this epidemiological variation can be understood in terms of the basic-case
reproduction rate (BCRR) of malaria, a convenient measure of transmission.  The BCRR is the mean
number of new cases of malaria to which one case will give rise directly after a single passage through
the vector mosquitoes, under conditions of no immunity in the human population.  Thus with a BCRR
of five, one case will give rise to five cases in the next generation and 25 in the succeeding generation
of cases; spread will continue potentially until all the people are infected.  Conversely, should the
BCRR fall below one, the disease will tend to gradually die out: the goal of malaria-transmission
control may be formulated as keeping the BCRR below one.  In an endemic malaria situation, the
supply of uninfected susceptibles will run out and acquired immunity will play a key role.  Three
characteristics of the female anopheline mosquito largely determine the BCRR: the density of
mosquitoes, man-biting habit and longevity.
Mosquito density is conveniently measured in terms of the number of female mosquitoes per
human inhabitant of the area.  Malaria transmission is proportional to mosquito density, as might be
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expected.  However, the effects of changes in the man-biting habit and longevity upon malaria
transmission are greater.  The man-biting habit is the chance that a given female mosquito will feed on
man on any one day.  Mosquitoes may feed as often as alternate days, and if all meals were upon man,
the man-biting habit would be 0.5.  For a mosquito that fed only every third day and with only 20 per
cent of meals upon man (the rest upon domestic stock) the man-biting habit would be less than that of
the other species by a factor of 7.5.  However, since transmission is proportional to the square of the
man-biting habit because it takes two bites to transmit malaria––one to infect the mosquito and one to
infect man again––the second mosquito is 56 times less effective as a malaria vector.  Mosquito
longevity affects malaria transmission even more.  It takes time for the parasite to develop within the
female anopheline.  The minimum time is temperature-dependent but even in the hot tropics at least ten
days must elapse between the bite that infects the mosquito with malaria and the first time the mosquito
is able to pass on the infection.  Mosquitoes are often quite short-lived, with a steady daily mortality of
five to 25 per cent of the population, so that very few mosquitoes that catch malaria survive to pass it on
in many vector species.  A really long-lived species can however be extremely effective at passing on
the infection.  In a sense the ‘geriatric’ mosquitoes are responsible for malaria transmission.
The preceding discussion shows that, for effective malaria transmission, a mosquito species needs
to be long-lived and have a high man-biting habit.  Both the vector-species complexes that are largely
responsible for African malaria transmission feed preferentially on people, feed frequently, and are
long-lived in nature.  They include the world’s most efficient malaria vectors.  Any value for the basic-
case reproduction rate of malaria (BCRR) in excess of one will allow spread of the infection.  In parts of
Asia such values as three and five are not uncommon in malarious areas.  In sub-Saharan Africa values
for the BCRR in excess of 1,000 are found.  There is therefore in many parts of Africa a vast excess of
capacity for malaria transmission above that required to maintain endemicity.
This very high BCRR is responsible for the key features of malaria in much of Africa: it is
extremely hard to control transmission effectively since so great a proportionate reduction in
transmission, perhaps a thousandfold, is needed before the infection dies out; secondly, everyone tends
to become infected at an extremely early age and exposures to infection are usual in the first year of
life; thirdly, because of the high level of transmission, the natural variations in the determinants of
transmission from one year to another never bring the BCRR down close to one so that malaria is
always highly endemic.  This situation is called ‘stable’ malaria because it varies so little, and malaria
epidemics are unknown in much of the continent: in other words it is ‘too unhealthy for epidemics’!
The chief determinant of the pattern of malaria seen in Africa is thus the pattern of acquired immunity
to human malaria.  If this did not occur, in many regions of Africa all the inhabitants would have
malaria parasitaemia every day of their lives.  The pattern of infection under the extreme of stable
perennial transmission is called holoendemic malaria.
Malaria transmission and community impact
The relation between malarial transmission and its disease effects on the community has been the
subject of some of the most vehement controversy in tropical health.  This has centred on the problems
of African holoendemic malaria––the effects of epidemics have been relatively unequivocal––and
conflict was probably heightened by underlying differences of philosophy between the two schools of
thought involved.  One view was that an equilibrium is reached between parasites and the human
community under the conditions of holoendemic malaria; this was most thoroughly propounded by
Wilson, Garnham and Swellengebel (1950).  They were impressed by the limited morbidity and lack of
mortality among indigenous adults, conscious of the difficulty of interrupting transmission with residual
insecticides, and fearful of the increased lethality of the disease that might follow unsuccessful control
attempts.  Their philosophy could be represented as not interfering with a naturally-established
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equilibrium and had conservationist implications.  By contrast, the other group, led by Macdonald
whose 1951 paper is a model of forensic logic, and including Russell and Soper, were convinced of the
need to vanquish malaria, and were confirmed interventionists with a strong commitment to
eradication.1  Their philosophy saw nature as red in tooth and claw, and they were conscious of the
price in infant deaths that had been paid to achieve equilibrium by adult life.  Macdonald in particular
had been immensely impressed by the fall in infant mortality in Freetown, Sierra Leone, that followed
larviciding operations, as he had worked there (Macdonald and Chowdhuri 1926).  The
‘interventionists’ can be said to have won the day in 1950, and their research on the effects of control
measures has provided much of the best evidence for the impact of malaria upon mortality, discussed
below.
Sources of information on consequences of malaria
The problems of diagnosis in rural clinics mean that routine reporting is not a source of reliable data.
Nevertheless, information from numerous routine sources, particularly from West Africa, show
‘malaria’ to be one of the major clinical problems.  Of eleven common diagnoses in Sierra Leone,
malaria accounted for 18–35 per cent of the year-of-age specific diagnoses in young children at an
outpatient department; it was the commonest cause both of hospital admission and of death in a hospital
in north-west Uganda, though it occupied a much less prominent position in relation to adult patient
diagnoses.  In paediatric health-care facilities throughout tropical Africa, the three predominant causes
of ill-health recorded are respiratory infections, diarrhoeal diseases and malaria, though the precise
order in which they are placed depends on the region, the age-category under study and the type of
health-care facility.  Where more sophisticated approaches to the overall burden of ill-health are used,
as has been done in Ghana (Ghana Health Assessment Project Team 1981), malaria emerged as the
chief cause of loss of days of healthy life, an aggregate measure of the consequences of mortality,
illness and disability.  Malaria was responsible for 10.2 per cent of all healthy life lost from disease,
amounting to 33 days per person per year, though of course much of this was due to deaths in infancy
from malaria.  Where attempts were made to transform this into economic loss in a fairly direct way,
malaria remained the leading cause of loss with discount rates of zero and five per cent, falling to fifth
place at a rate of ten per cent.
Scale of malarial mortality
There are three main ways of attempting to measure mortality due to a disease such as malaria: from
clinical records as to the cause of death, from observing the rise in mortality during malaria epidemics
and by determining the fall in mortality when malaria is brought under control.  Molineaux (1985) has
reviewed some examples of the consequences of malaria control and has also added a fourth method of
assessing malaria mortality which depends on calculating the mortality necessary to maintain the
observed level of the sickling gene in a balanced polymorphism.
The scarcity of post-mortem series in Africa and, more seriously, the extreme bias introduced
because they only derive from tertiary-care facilities and very rarely include young children and infants,
mean that what is usually viewed as the best possible source of accurate data is not useful for assessing
malarial mortality in Africa or other developing countries.  Clinical records of cause of death are
equally unsatisfactory as most people die outside hospital; malaria is a very treatable condition unless it
presents at hospital very late, and only those exceedingly ill are likely to be admitted.  Add to this the
scarcity of paediatric beds in many hospitals and it is clear that information on death certificates will be
a poor guide to what is happening in the community.  Nevertheless, malaria is the commonest cause
                                                
1 In the case of Soper, well-founded in experience in Brazil and Egypt.
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both of admission and of death in children under five years of age in a Ugandan community hospital
(Williams, Hayes and Smith 1986).  Epidemic malaria is rare in Africa, and relevant data come from
outside the continent where the great epidemics of falciparum malaria in Punjab and Sri Lanka led to
dramatic changes in mortality.  In Sri Lanka the quarterly crude death rate at the height of the epidemic
rose by a factor of 3.4, implying that two-and-a-half times more people died of malaria than of all other
causes combined during that period.  The Sri Lankan data on vital rates are sufficiently good to have
been used in numerous, and controversial, analyses of the impact of malaria, discussed critically by
Molineaux (1985).  Perhaps the most informative picture comes by comparing the least and most
malarious districts over a long period that includes the introduction of malaria control.  This suggests
that the crude death rate of the highly malarious district was consistently double that seen in the other,
though the two had identical death rates after malaria control.
The best African data on malarial mortality derive from local field-research projects that have
attempted to stop malaria transmission, usually by means of residual insecticides, though some recent
projects have relied increasingly on chemotherapy and chemoprophylaxis.  Of particular interest have
been those where observation has continued after attempts at transmission control have been
abandoned.  All are research-scale because national-scale interruption of transmission has not been
feasible in sub-Saharan Africa.  The exceptions have been small islands, or areas at the edge of
transmission due to temperature, in turn due to high altitude or location towards the southern limits of
transmission; or at the northern limits from aridity.  None of these situations is generally informative
about the African situation.  Three major field projects have used residual insecticides to lower
drastically the transmission of malaria over substantial but research-scale patches of Africa.
The Pare-Taveta scheme was the earliest, with spraying from 1955, and in broad design the most
elegant, since after several years the intervention ceased and the degree of reversion could be observed
(Bradley 1991).  Unfortunately, emphasis was originally placed on research areas other than infant
mortality, there was a hiatus in demographic data collection, and the long-term demography was carried
out subsequently in a slightly different but more detailed way.  Striking findings on growth and
morbidity were the apparent absence of malarial effect.  Malaria was, however, clearly shown to be of
importance in producing a substantial and widespread reduction of the haemoglobin level.
Mortality data, initially on a limited population, showed substantial year-to-year variation but a
clear and large fall in the first year of full spraying, 1956; death rates remained down for the spraying
years to 1958.  After the spraying ceased and demographic-data collection had been resumed on a larger
scale (1962–1966) there was a small mortality rise in the infant and over-40-years age groups, and a
large reversion to the previous high death rates in the 1–4 years age group.  It should be noted that
malaria transmission only gradually resumed when spraying ceased and had not reached former levels
even by 1966.  Also, concern had been felt about stopping the spraying and there followed deliberate
attempts to make antimalarials available to the population, so that not only was a complete reversion of
vital rates highly undesirable, but efforts were made to prevent it.  Other changes in socioeconomic
progress were taking place, and drought also complicated the scene.  Nevertheless, the immediate,
precipitous fall in death rates, especially in infants and young children, as soon as spraying was
complete, is very convincing.  In particular, the infant mortality rate fell from a level of 165–260 before
control to 78–132 after it had been instituted, a fall of 108 which amounted to a halving of the infant
mortality rate.  The young children aged 1–4 years also had a halved mortality, though it was of course
much smaller than the IMR; falls in deaths in older people were less dramatic.
A second similar study, in the Kisumu area of Kenya, to the north-east of Victoria Nyanza, took
place nearly 20 years later and used Fenitrothion to achieve a 96 per cent reduction in malaria
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transmission.  This was accompanied by a fall in the infant mortality rate of 40 per cent, from 157 to 93
per thousand.  The malarial effect was greatest between three and ten months of age (Payne et al. 1976).
The third study, and that best documented and executed, was in the Garki area of northern Nigeria
in 1971–1973, with extremely intense seasonal-malaria transmission.  Intervention was by residual
insecticide spraying with Propoxur, backed up by mass drug administration for part of the area, which
had a very substantial effect in reducing transmission.  Infants were not given drugs unless they were
found to be infected (Molineaux and Grammiccia 1980; Molineaux 1985).  The most dramatic findings
were a large fall in the infant mortality rate from 255 to 55 and 102.  Comparable unprotected villages
had an IMR greater by 80 and 90 in the two intervention years.  The death rate of children aged 1–4
years was less than half that in unprotected villages as was the crude death rate.  Moreover, in the
absence of protection there was a close seasonal parallel between the IMR and the rate of conversion of
infants to parasite positivity, with the IMR about ten per cent of this rate-of-incidence measure.  Under
protection the IMR both fell and lost its seasonal peaks.
In Senegal, the first of three chemotherapy and chemoprophylaxis trials (Garenne, Cantrelle and
Diop 1985) halved the mortality of those aged six months to 35 months, but had no effect on those
older, or younger.  Moreover, there was a large fall in the diagnosis ‘fever and malaria’ as the stated
cause of death.  As this was rather precisely balanced by a rise in the ‘miscellaneous or not known’
category for other causes of death, Carnevale and Vaugelade (1987) have cast some doubt on this
interpretation.
Subsequent studies in the Congo at Kinkala, and in Bobo Dioulasso (Burkina Faso) as studied by
Baudon et al. (1984), showed very little effect of intense chemoprophylaxis and chemotherapy upon
mortality and are difficult to reconcile with the weight of other evidence except on some of the
hypotheses considered below.
Historical assessment of malaria morbidity: inferences from genetics
The gene for sickle-cell anaemia, when present in homozygous SS form, is effectively lethal before
reproduction.  For this gene to be maintained in the population, the heterozygous AS form must have a
selective advantage over the normal homozygous AA.  It is believed that this advantage consists of a
relative protection against the lethal effects of falciparum malaria.  If the relatively conservative
assumption be made that all AS individuals have a zero death rate from malaria, it is possible to
calculate the minimum malaria mortality of the AA group, and thus of the whole population, needed to
maintain the S gene at any observed equilibrium frequency.  The sickling gene reaches a very high
frequency in parts of sub-Saharan Africa and may reach a frequency of 40 per cent of sickle-cell trait
carriers.  At a level commonly encountered in East Africa of 18 per cent of sickle-cell traits, AS (or a
gene frequency of 10% S), and assuming complete loss of sicklers before puberty, then an excess
mortality of the order of 100 per thousand is required from malaria in the AA genotype people, or an
excess of some 81 per thousand in the overall population.  In other words, if the total cumulative
mortality in the population by puberty is of the order of 300 per thousand, over a quarter of this
mortality would be due to malaria to maintain the gene frequency in equilibrium.  If any of the AS die
of malaria, the proportion of malaria deaths would need to be greater.
An incidental consequence of the way in which the gene frequencies are maintained in balance by
a ‘proportional mortality of genes’ is that where the non-specific infant mortality is high, a lower
mortality from malaria per thousand live births will be needed to maintain the same gene frequency.  To
maintain the ten per cent sickle-cell gene frequency (18% sickle-cell trait) requires a mortality of 90 per
thousand from malaria where this is the only cause of death, 81 at a non- malaria mortality of 100 per
thousand before puberty and 72 at a non-malaria mortality of 200.  To maintain 32 per cent
heterozygosity in a population with 200 per thousand premature deaths from other than malaria,
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requires a malarial mortality of 128 per thousand and 200 per thousand AA individuals, or doubles the
mortality in the AA group.
Interpretations of malaria mortality
In reviews of differing aspects of malarial mortality, Molineaux (1985) and Carnevale and Vaugelade
(1987) have considered the empirical evidence.  Any attempt to put together the apparently conflicting
evidence must take one of three broad approaches.  One is to deny the validity of some of the data.  This
is not difficult as all the studies have methodological defects, some bristle with assumptions, and many
have broad confidence limits even if the observations are correct.  There is therefore much space for the
author to choose the conclusions he prefers and to explain away discrepant results.  This tends to be
Carnevale’s approach.  The second way of dealing with the range of results on mortality is to assume
the existence of confounding variables that affect the scale of the observed mortality that is ascribed to
malaria.  This view is adopted by Molineaux and developed by Cohen (1988).  A third view, perhaps a
variant of the second, is to assume heterogeneity of the consequences of equally endemic malaria due to
interventions of other types, a position which can explain some of the problems confronting Carnevale.
Molineaux (1985), in an exceptionally careful and imaginative analysis of the data on malaria
mortality, deals with two problems.  The first is the much greater reduction in mortality observed after
malaria control operations than the fall in deaths ascribed specifically to malaria would suggest.  This is
most apparent in non-African data, from Guyana and Sri Lanka, where an indirect effect of malaria
control on mortality, 2–4 times the direct reduction of deaths from malaria, was observed.
A converse effect appears to prevail in two West African studies, where the removal or massive
reduction in deaths from malaria has led to a much smaller fall than expected in infant and young child
mortality.  This was seen in Garki, Nigeria (Molineaux and Grammiccia 1980), where malaria control
removed the seasonal peaks of malaria deaths but mortality remained high overall, and in The Gambia
when a measles epidemic shifted the peak season of infant mortality from the malaria season without
massive effects on total mortality.  The most economical hypothesis to explain these results is that of
competing risks: a certain number of children are postulated as likely to die anyway, possibly with low
birth weights and for other ultimate reasons, and the immediate cause of death may be malaria if present
and some other infection if malaria is absent.  Both malaria and, say, measles may be sufficient causes
and only one is necessary.  In either situation, deaths averted by malaria control are not equal in number
to deaths due to malaria.  With the twin explanations of indirect malarial mortality and competing risks,
it is of course dangerously easy to explain most sets of paradoxical results.  In a long-term study many
other variables also change; this fact limits the ability to refute some of these possible explanations of
observed data.
Carnevale and Vaugelade (1987) are primarily concerned with African data that suggest a fall in
adult as well as infantile mortality after malaria-control operations, and with the relatively small effects
seen in some recent control projects, mainly using chemotherapy, in francophone Africa.  Although
they argue from the earlier campaigns forwards, it is reasonable to infer that the main starting points
were their own and colleagues’ recent work in Burkina Faso and in the Congo which showed very little
reduction in mortality among children subject to a vigorous chemoprophylactic and chemotherapy
regime.  The earlier Senegalese study is open to criticism on diagnostic grounds. Carnevale and
Vaugelade (1987) then attempt to undermine the conclusions of the three major control programs in
Pare-Taveta, Garki and Kisumu, arguing that, first, the decline in mortality is general and progressive,
owing to social and economic development along with a broad-based improvement of medical care, and
secondly the insecticidal and chemotherapeutic programs are non-specific, contrary to what has been
generally asserted.
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It is certainly true that several of the communities studied have improved economically and in
access to health care over the periods studied and this is likely to have been responsible for some of the
changes observed, as discussed above, and the Kisumu changes are difficult to explain on any grounds.
But the rapidity of the effects in Pare-Taveta and Garki argue strongly for a specific antimalarial
intervention as the primary determinant of the main changes observed and described above.
The argument that residual insecticiding is non-specific in its effects is unconvincing.  A more
likely hypothesis is that the earlier studies did indeed demonstrate substantial malarial mortality; that
the ones, intermediate in time, at Kisumu and at Ngayokhem in Senegal, have methodological problems
that make them hard to interpret reliably; and that the recent francophone-country studies showed little
benefit from organized chemoprophylaxis or chemotherapy because mortality from malaria had already
been reduced by various forms of progress but chiefly by individuals purchasing chemotherapy for their
families when febrile.
The studies are all compatible with heavy infant mortality in uncontrolled holoendemic malaria,
greatly reduced by individual access to chemotherapy in recent years.
Epidemiological trends
In spite of its epidemiologically ‘stable’ nature, African malaria is undergoing substantial and rapid
change at present in its basic epidemiology, in the pattern of mortality and in the pattern of resistance
displayed by P. falciparum to antimalarial drugs.  It is possible that in the medium-term immunization
methods may become available to produce a fourth and massive type of change.
Several types of change in malaria transmission are taking place at present.  In the Sahel and
savannah areas where lack of surface water prevents transmission for several months of each year, the
development of water-storage dams and of irrigation, particularly for rice production, is extending the
breeding season for anophelines and increasing mosquito populations.  Few new large dams are now
being built, but small dams proliferate, often without any form of health assessment, and though their
effect on malaria should not be exaggerated, they will have some effect in the more arid areas.
Urbanization is proceeding rapidly and it has been predicted that up to 43 per cent of the population of
Africa may live in urban areas by the year 2000.  Usually the effect of urban development has been to
decrease anopheline densities substantially.  Pollution of urban surface waters has led to a marked
increase in the ‘dirty water’-breeding culicines such as Culex quinquefasciatus and a fall in the
mosquitoes that flourish in clean water, such as the anophelines, and this has been well documented in
Dar es Salaam.  In South Asia, however, urban malaria is common because of the urban anopheline, An.
stephensi. which is also a very good vector.
The widespread availability of some antimalarials, chiefly chloroquine, has undoubtedly affected
the mortality from malaria in children.  In some places, few fevers, whether due to malaria or not,
escape partial if not complete courses of chloroquine and this has brought down the number of fatalities.
Within the remaining areas of chloroquine sensitivity this trend will continue.  It has already been
argued above that this provides a better explanation of the apparently changing effects of malaria
control on population mortality than do the suggestions of lack of specificity of the earlier insecticidal
programs.  Sir Ian McGregor (personal communication) has described the appearance of cerebral
malaria in teenagers in Banjul, The Gambia, where it was previously a disease of infants.  The
combination of urbanization in reducing transmission, and frequent chemotherapy or even
chemoprophylaxis in diminishing individual duration of parasitaemia, have probably been responsible
for this.
If the malaria parasites had remained unchanging, the steadily increasing availability of
antimalarials at health-care facilities and shops, and consequently in the home, would be expected to
have led to a progressive decease in malarial mortality so that it would have remained a major cause of
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disease but become of limited importance as a cause of death.  However, the spread of drug-resistant
strains of P. falciparum is greatly altering this optimistic picture.  Resistance to the folic-acid
antagonists proguanil and pyrimethamine emerges rapidly after their widespread use, and
pyrimethamine resistance is common in many parts of the tropics.  But the crucial resistance has been to
chloroquine which has dominated the treatment of malaria in the past because it is efficacious, cheap,
relatively non-toxic, and easy to administer.  The spread of chloroquine-resistant P. falciparum since
1950 has created a new situation.  It spread from foci in Colombia and on the Thai-Vietnam border to
envelop Southeast and South Asia, and then reached Africa a decade ago.  The last five years have seen
very rapid spread across Africa.  It is common in East and Central Africa and has reached Cameroon,
Ghana, and other West African states.  It will soon have reached all the states of West Africa.
The second-line therapeutic drug is Fansidar (a mixture of pyrimethamine and a long-acting
sulphonamide) which is more toxic and much more expensive, and to which resistance has been clearly
described in East and part of Central-Southern Africa as well as in Asia.  Alternatives for treatment are
also expensive, resistance emerges quickly to mefloquine, and quinine is both toxic and more difficult
to administer than other antimalarials.  Chloroquine resistance and Fansidar resistance will surely
continue to spread and the scanty number of new drugs to be available in the near future (halofantrine,
artemether, etc.) suggests that mortality from malaria may cease to decline, and in areas where drugs are
already used may begin to rise.  The outlook is not good, in the absence of major innovations, among
which a vaccine is the item on which most hopes are based.
Changes in approaches to control
The history of malaria was for many centuries about an increasing understanding of the circumstances
under which it flourished, together with some preventive action, and a concurrent clinical understanding
of the pattern of fever and association with splenomegaly that goes back to ancient China.  Therapy
improved substantially in the seventeenth century with the introduction of quinine, but otherwise the
modern era began in the 1880s.  As with all infectious and communicable diseases, in the late
nineteenth century the field became dominated by microbiology and the causative Plasmodium was
described in 1882.  Although description of the stages of the life cycle in the mosquito by Ross soon
followed, malaria was remarkable for concealing some of its parasitological secrets so that the whole
life cycle, including the hypnozoite stages, took a complete century to unravel.  However, malaria was
equally remarkable for the very rapid translation of parasitological research to preventive action.  This
was mainly due to the orientation of Ross towards practical control.  On demonstrating the mosquito
transmission of Plasmodium, Ross turned from parasitological research to field control at once and the
‘mosquito theory’ was put to use within a few years, with great success, particularly by Watson in
Malaysia and Gorgas in Panama.  The subsequent rate of malariological research steadily increased, and
while the frantic pace of modern molecular biological research is a very recent phenomenon, enormous
progress was made in the first half of this century in many aspects of malaria, and also of control.
The nineteenth century saw great improvements in the control of communicable disease, chiefly as
a consequence of environmental improvements.  The provision of a safe piped water supply to every
household was the most striking of a series of measures to improve the health of the population as a
whole.  This may be described as the public-health approach.  The public-health approach (in this
limited sense) to malaria is reduction in transmission, aiming to protect everyone.  An alternative
approach to disease control has been to seek to protect the individual. In malaria, this goes back to the
use of quinine as a prophylactic and is most clearly seen today as the use of chemoprophylaxis by
travellers to malarious areas and the provision of chemoprophylaxis to pregnant women in endemic
areas.  It is more concerned with preventing death or disease than with protecting the whole community.
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It bears a closer relation to clinical medicine than does transmission control, and lends itself to
distribution through a curative primary health-care system.
The broad public-health approach of our ancestors looked to environmental control leading to a
man-made landscape under careful control and a fertile economy.  Into this fits species sanitation: the
selective alteration of the environment to prevent breeding of the local anopheline vectors of human
malaria, which was so successful in areas of relatively lower vectorial capacity and especially organized
plantation agriculture in the tropics.  For the first two decades of this century, both environmental
control of mosquito breeding and various patterns of chemotherapy were tried.  Successes on the grand
scale for the Panama Canal, Zambian copper belt, and South Asian tea plantations made the public-
health approach dominant for areas where organized control of the environment was feasible, usually
where there was a commercial opportunity and investment for development.  The elaboration of a
sophisticated species-sanitation approach provided a sound basis for this.
The discovery of the residual insecticidal properties of DDT changed the method of control
completely and made large-scale area-wide control feasible from the 1940s (Table 1).  It also shifted
any previous focus on individual protection from bites by personal action towards centralized public-
health efforts and strengthened the predominance of transmission control.
Table 1
An attempt to epitomize the decades since 1930 in malaria control
Malaria
1940
Control
1950
Eradication: attack
1960
Eradication: consolidation
1970
Resurgence
1980
Chaos
1990
Hope
Eradication took this further still in the 1950s onwards.  Not only was the interruption of
transmission the central goal, but chemotherapy of individuals in the consolidation phase was viewed as
an attack on transmission rather than as therapy for individual benefit.  There was an extreme loss of
interest in the malaria patient as such, and also in research.  Eradication of malaria was treated rather as
a military campaign; many of the workers were not from the health-care system and the program was
usually kept separate from the remainder of the health services, at any rate until well into the
consolidation phase.
Malaria became, in a unique sense, the World Health Organization’s disease.  It staked its
reputation and half its staff on eradicating malaria.  The initial successes of the eradication policy, the
lasting benefits for many countries, and the subsequent difficulties in the consolidation phase over time,
are well known and need no repetition here.  The resurgence of malaria in India (Figure 2) illustrates
what was seen elsewhere throughout Asia, while eradication was scarcely attempted in much of sub-
Saharan Africa.
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Figure 2
In the long and disorderly sorting out of policies during the decades of resurgence and chaos (see
Table 2) there has been a shift towards a risk approach, in several steps.  This approach of preventing
deaths and shortening illness was conceded initially with reluctance to communities otherwise unable to
cope with controlling malaria, and has gradually become more vigorously advocated by WHO.  Much
of this has been related to resolving tensions between malaria-control strategies and the primary-health-
care concept which succeeded malaria eradication as a driving ideology at WHO, though both ideas are
now moving to more empirical approaches, partly driven by economic pressures.
Table 2a
Recent estimates of the numbers of people exposed to or suffering from malaria within a year,
expressed as an annual period prevalence
Exposed 2,073 million
Infected 270 million
Ill 110 million
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Died 1 million
Table 2b
Current risk of malaria in relation to past eradication efforts in the world.  There is considerable
lumping of data by countries which exaggerates the ‘reduced’ category.  Population in each of
four categories
Never malarious 1,300 million
Eradicated 800 million
Reduced 2,120 million
No control 370 million
Nobody can look at the list of available antimalarials today with any complacency: the safe drugs
are rapidly becoming ineffective, and the more effective drugs are either new or relatively toxic or both,
and are expensive.  New drugs may well be followed by parasite resistance, or previously inadequately
perceived toxic effects may emerge, as was the case when amodiaquine was used for prophylaxis on a
larger scale.  And the list of candidate new drugs is tiny.  As chloroquine resistance spreads to cover
Africa, what remains that is both safe and cheap?  The situation cannot change overnight as the
gestation period for a new drug is long––nearer a decade than a year––and few join the queue to enter.
Hopefully, the present decade will see a transition from chaos to hope in malaria control.  Vaccines
could transform the scene, but even if not, there are advances taking place in many aspects of malaria
control, such as the use of insecticide-impregnated bednets.  As we learn the new, we must not forget
the old.  It is now necessary to combine these various accounts of epidemiological and control processes
and of historical events into a coherent whole and in relation to the idea of a health transition.
In summary, there have been substantial changes in the mortality from malaria both in the African
holoendemic situation where availability of personal chemotherapy has increased, and in Asia and Latin
America where eradication attempts greatly reduced transmission and where mortality from resurgent
malaria has again been handled by chemotherapy.
In finer detail, transmission has only fallen in those parts of Africa where urbanization has polluted
the vector-breeding sites, where desertification has greatly curtailed the transmission season and where
malaria control has been practised at the altitudinal or latitudinal limits of transmission.  As
transmission persists at a much higher level than is needed to maintain all the population infected (or
subsequently partly immune), there continues to be a great threat to life of the young, comparable to
that observed in the past in the Pare-Taveta study or inferred from the sickling frequency.  This is only
held in check by early chemotherapy of those ill from malaria.  With the spread and intensification of
chloroquine resistance, followed by multidrug resistance, in P. falciparum, malaria mortality is tending
to rise again and this is likely to continue with the relative paucity of new drugs entering the market,
and their high cost, unless an effective and cheap vaccine becomes available.
In the other malarious areas of the world, transmission was dramatically reduced, and almost
halted in places by the eradication programs of the period 1950–1970.  Both mortality and infection
became very low.  In Europe, the USA, and several small islands eradication was successfully achieved.
In South Asia, Indonesia, and other large areas a massive resurgence of transmission took place
following the collapse of the eradication programs, so that, for example, the annual incidence of malaria
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in India, around 100 million cases a year in the 1930s, fell to 200,000 at the best year for eradication,
and then rose again to reach levels of the order of 20–40 million annually after allowing for
underreporting of cases.  Urbanization did not reduce malaria as An. stephensi is an urban breeding
mosquito and a good malaria vector.  Mortality did not rise proportionately with the resurgence of
transmission, presumably because of chemotherapy, but the spread of chloroquine resistance is making
this more difficult.  Nevertheless, the level of transmission is lower than in sub-Saharan Africa and this
makes control an altogether more tractable proposition.
Changes in malaria 1930-1991
The course of malaria as a world problem has therefore been one of massive incidence and prevalence
with great mortality up to the 1940s, with control taking place in limited areas of commercial
agriculture or urban development where funds were available and the level of transmission was not too
high.  Some of these situations, such as parts of the USA and Europe, were in the demographic and
health transitions, but others such as the tea-gardens of South India could not meaningfully be so
described.  No impression was made on sub-Saharan African lowland malaria where malaria mortality
might approach 50 per cent of infant and young-child deaths, or a rate of over 60 per thousand births.
The decade following the Second World War saw the use of DDT on an increasing scale.  Around
the Mediterranean almost total control was achieved in countries of very varied standards of living, as
also happened on various small islands in the Caribbean and elsewhere, regardless of where they were
in relation to a demographic transition.  Success in control, short of eradication, then followed in many
relatively poor countries of Asia and Latin America through the use of residual insecticides, chiefly
DDT, often paid for by foreign-aid funds.  Good results needed a rudimentary health service capable of
being improved and a low or medium BCRR.  Temporary successes were recorded in countries as poor
as Bangladesh, Sri Lanka and India.
From 1970, eradication had been achieved in European countries and the USA, places with
relatively high-income, well-organized health services, and also less efficient malaria transmission or a
short transmission season.  Successes were also attained on some islands without those criteria.  In Asia,
difficulties in getting rid of the last cases through problems at the consolidation phase first prolonged
that phase and eventually were followed by collapse of the eradication programs, which were rigid, and
conspicuously lacking in research support.  Failure was variously blamed on insecticide resistance of
the mosquitoes, administrative failure of the consolidation case-finding program, resistance to drugs by
the parasites, generally weak health services, and so on.  The process was complex and often country-
specific.  Eradication is a high-risk activity that has to be oversold to have any hope of success and then
must maintain activity and funding in the face of a disappearing health problem, and push eradication to
completion in less than a decade, before political will is exhausted.  In many poorer countries the
remarkable fact is not that eradication failed but that it came so close to success.  The outcome also
depended on the BCRR as this determined the difficulty of the task.  The same effort in Sri Lanka and
Sierra Leone would eradicate malaria from the former while having a negligible effect on the latter.  For
practical purposes, sub-Saharan tropical Africa wisely did not participate in the eradication program and
the holoendemic malaria there persisted.
During the 1970s and 1980s resurgence of malaria occurred in those countries where eradication
had not succeeded. P. vivax preceded P. falciparum, as is usual in malaria epidemics.  The level of
endemicity reached was usually lower than in the 1930s and in particular the mortality appeared much
lower, though official reluctance to acknowledge the failure of the program and the general collapse of
morale and malaria control may have greatly impeded reporting.  The overall impression gained is that
malaria mortality is substantially reduced, probably from widespread self-medication with chloroquine.
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With the massive spread of P. falciparum resistance to chloroquine, and often multi-drug resistance, it
is likely that mortality will rise again, certainly in Africa.
Malaria and the demographic and health transition
Clearly, the relation between malaria and the so-called health transition and the demographic transition
is complex.  In African holoendemic malaria, significant control clearly affects the demographic
transition because malaria is such a major cause of infant mortality.  Even where this is less obvious, as
in Sri Lanka, the near-eradication period was characterized by a great rise in fertility and population
growth.
Apart from the direct contribution of malaria to mortality and fertility, where it is driving the
demographic processes that lead to the transition, malaria control is relatively autonomous as a health
variable.  Its feasibility is determined by the biological BCRR which depends on local mosquito
biology.  Certainly, because control requires resources and a health-care delivery system, it is related to
economic development.  It does not, however, disappear ‘spontaneously’ as incomes rise, it requires a
specific and well-organized effort to control transmission, though mortality does tend to fall once the
appropriate chemotherapy is widely available.
But the malaria parasite is also capable of adaptation, and drug resistance may result in malarial
increases that would not tidily fit a health transition that went one way.  Conversely, moderate effort on
islands with a relatively low BCRR can eradicate malaria at a stage long before the other aspects of the
health transition would occur.
Thus, for malaria, as for other vector-borne infections, any simple concept of a demographic and
health transition fits uncomfortably.  It is truer for malarial mortality than for malarial infection.  But
biological factors which show immense areal variation play a major role, and both recent technical
advances and ancient genetic mechanisms confuse the simple picture.  Malarial mortality reduction may
be part of the health transition, but the richness and diversity of malaria epidemiology and control
cannot be contained within so simple and general an idea.
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